S&P 500   4,202.09 (-0.08%)
DOW   32,970.07 (-0.37%)
QQQ   349.61 (+0.35%)
AAPL   177.06 (+0.93%)
MSFT   331.08 (-0.54%)
META   262.84 (+0.31%)
GOOGL   123.02 (-1.28%)
AMZN   121.31 (+1.00%)
TSLA   198.85 (+2.94%)
NVDA   403.14 (+3.51%)
NIO   7.39 (-4.03%)
BABA   78.28 (-3.32%)
AMD   125.84 (-0.94%)
T   15.60 (+0.65%)
F   12.59 (+4.14%)
MU   72.25 (-2.27%)
CGC   0.87 (-0.88%)
GE   102.14 (-0.58%)
DIS   87.18 (-1.26%)
AMC   4.59 (-1.08%)
PFE   37.07 (-1.41%)
PYPL   61.38 (+1.93%)
NFLX   390.69 (+3.12%)
S&P 500   4,202.09 (-0.08%)
DOW   32,970.07 (-0.37%)
QQQ   349.61 (+0.35%)
AAPL   177.06 (+0.93%)
MSFT   331.08 (-0.54%)
META   262.84 (+0.31%)
GOOGL   123.02 (-1.28%)
AMZN   121.31 (+1.00%)
TSLA   198.85 (+2.94%)
NVDA   403.14 (+3.51%)
NIO   7.39 (-4.03%)
BABA   78.28 (-3.32%)
AMD   125.84 (-0.94%)
T   15.60 (+0.65%)
F   12.59 (+4.14%)
MU   72.25 (-2.27%)
CGC   0.87 (-0.88%)
GE   102.14 (-0.58%)
DIS   87.18 (-1.26%)
AMC   4.59 (-1.08%)
PFE   37.07 (-1.41%)
PYPL   61.38 (+1.93%)
NFLX   390.69 (+3.12%)
S&P 500   4,202.09 (-0.08%)
DOW   32,970.07 (-0.37%)
QQQ   349.61 (+0.35%)
AAPL   177.06 (+0.93%)
MSFT   331.08 (-0.54%)
META   262.84 (+0.31%)
GOOGL   123.02 (-1.28%)
AMZN   121.31 (+1.00%)
TSLA   198.85 (+2.94%)
NVDA   403.14 (+3.51%)
NIO   7.39 (-4.03%)
BABA   78.28 (-3.32%)
AMD   125.84 (-0.94%)
T   15.60 (+0.65%)
F   12.59 (+4.14%)
MU   72.25 (-2.27%)
CGC   0.87 (-0.88%)
GE   102.14 (-0.58%)
DIS   87.18 (-1.26%)
AMC   4.59 (-1.08%)
PFE   37.07 (-1.41%)
PYPL   61.38 (+1.93%)
NFLX   390.69 (+3.12%)
S&P 500   4,202.09 (-0.08%)
DOW   32,970.07 (-0.37%)
QQQ   349.61 (+0.35%)
AAPL   177.06 (+0.93%)
MSFT   331.08 (-0.54%)
META   262.84 (+0.31%)
GOOGL   123.02 (-1.28%)
AMZN   121.31 (+1.00%)
TSLA   198.85 (+2.94%)
NVDA   403.14 (+3.51%)
NIO   7.39 (-4.03%)
BABA   78.28 (-3.32%)
AMD   125.84 (-0.94%)
T   15.60 (+0.65%)
F   12.59 (+4.14%)
MU   72.25 (-2.27%)
CGC   0.87 (-0.88%)
GE   102.14 (-0.58%)
DIS   87.18 (-1.26%)
AMC   4.59 (-1.08%)
PFE   37.07 (-1.41%)
PYPL   61.38 (+1.93%)
NFLX   390.69 (+3.12%)
CVE:SBM

Sirona Biochem (SBM) Stock Forecast, Price & News

C$0.14
0.00 (0.00%)
(As of 10:12 AM ET)
Compare
Today's Range
C$0.14
C$0.16
50-Day Range
C$0.08
C$0.17
52-Week Range
C$0.08
C$0.35
Volume
5,205 shs
Average Volume
91,143 shs
Market Capitalization
C$35.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SBM stock logo

About Sirona Biochem (CVE:SBM) Stock

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. Sirona Biochem Corp. has a research collaboration agreement with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop antiviral library of compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Receive SBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter.

SBM Stock News Headlines

The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
Closing Bell: Sirona Biochem Corp up on Friday (SBM)
Closing Bell: Sirona Biochem Corp flat on Wednesday (SBM)
Sirona Biochem Announces Debenture Financing
Sirona Biochem Receives Antiviral Testing Results
See More Headlines
Receive SBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-2,130,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$683,768.00
Cash Flow
C$0.00 per share

Miscellaneous

Free Float
N/A
Market Cap
C$35.27 million
Optionable
Not Optionable
Beta
-0.30

Key Executives

  • Dr. Howard J. Verrico M.D. (Age 62)
    Ph.D., Founder, Chairman, CEO & Sec.
    Comp: $161.28k
  • Mr. Christopher D. Hopton C.G.A. (Age 57)
    CPA, CFO & Director
    Comp: $147.84k
  • Dr. Géraldine Deliencourt-Godefroy Ph.D.
    Chief Scientific Officer & Director
  • Ms. Michelle Seltenrich MBA
    VP of Operations
  • Dr. Brett A. Premack Ph.D.
    Scientific Consultant













SBM Stock - Frequently Asked Questions

How have SBM shares performed in 2023?

Sirona Biochem's stock was trading at C$0.12 at the beginning of 2023. Since then, SBM shares have increased by 21.7% and is now trading at C$0.14.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Sirona Biochem own?
What is Sirona Biochem's stock symbol?

Sirona Biochem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SBM."

How do I buy shares of Sirona Biochem?

Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Sirona Biochem's stock price today?

One share of SBM stock can currently be purchased for approximately C$0.14.

How much money does Sirona Biochem make?

Sirona Biochem (CVE:SBM) has a market capitalization of C$35.27 million and generates C$683,768.00 in revenue each year.

How can I contact Sirona Biochem?

The official website for the company is www.sironabiochem.com. The company can be reached via phone at 604-641-4466.

This page (CVE:SBM) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -